Human Genome Epidemiology Literature Finder
Records 1 - 7 (of 7 Records) |
Query Trace: Lymphoma and MTOR[original query] |
---|
Association of AMP-activated protein kinase with risk and progression of non-Hodgkin lymphoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 Feb . Hoffman AE, Demanelis K, Fu A, Zhang T, Zhu Y |
Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer. Cancer chemotherapy and pharmacology 2017 Jul . Mbatchi Litaty C, Gassiot Matthieu, Pourquier Philippe, Goberna Alejando, Mahammedi Hakim, Mourey Loic, Joly Florence, Lumbroso Serge, Evrard Alexandre, Houede Nadi |
Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma. Neoplasia (New York, N.Y.) 2018 May 20 (6): 574-593. Wang Xiaoxiao, Cao Xin, Sun Ruifang, Tang Charlene, Tzankov Alexandar, Zhang Jun, Manyam Ganiraju C, Xiao Min, Miao Yi, Jabbar Kausar, Tan Xiaohong, Pang Yuyang, Visco Carlo, Xie Yan, Dybkaer Karen, Chiu April, Orazi Attilio, Zu Youli, Bhagat Govind, Richards Kristy L, Hsi Eric D, Choi William W L, van Krieken J Han, Huh Jooryung, Ponzoni Maurilio, Ferreri Andrés J M, Møller Michael B, Parsons Ben M, Winter Jane N, Piris Miguel A, Li Shaoying, Miranda Roberto N, Medeiros L Jeffrey, Li Yong, Xu-Monette Zijun Y, Young Ken |
Long noncoding RNA PVT1: A highly dysregulated gene in malignancy. Journal of cellular physiology 2019 7 235 (2): 818-835. Ghafouri-Fard Soudeh, Omrani Mir Davood, Taheri Mohamm |
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways. Blood advances 2021 10 6 (2): 637-651. Witte Hanno M, Künstner Axel, Hertel Nadine, Bernd Heinz-Wolfram, Bernard Veronica, Stölting Stephanie, Merz Hartmut, von Bubnoff Nikolas, Busch Hauke, Feller Alfred C, Gebauer Nikl |
Targeted sequencing reveals the relationship between mutations and patients' clinical indicators, blood cell counts and early progression in diffuse large-B cell lymphoma. Leukemia & lymphoma 2022 10 64 (1): 140-150. Ma Guangyu, Gao Yuhuan, Jing Xiaotong, He Cuiying, Liu Haisheng, Wu Xiaolin, Gao Zhe, Li Yuan, Zhang Shengnan, Zhao Guim |
Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORM. JCO precision oncology 2023 6 7 e2300015. Anna-Elisa Heipertz, Kristian W Pajtler, Elke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, Till Milde, Barbara C Jones, Cecilia Zuliani, Caroline Hutter, Olli Lohi, Antonis Kattamis, Iwona Dachowska-Kalwak, Anna Nilsson, Nicolas U Gerber, Karin P S Langenberg, Bianca Goemans, C Michel Zwaan, Jan J Molenaar, Natalie Jäger, Uta Dirksen, Ruth Witt, Stefan M Pfister, David T W Jones, Annette Kopp-Schneider, Olaf Witt, Cornelis M van Tilbu |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: